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Lymphocyte cytotoxicity for target cells is a method for evaluating specific lymphocyte 
stimulation. In vitro Iymphocytotoxicity has been demonstrated in chronic ulcerative colitis 
and granulomatous colitis, polymyositis and dermatomyositis, systemic scleroderma, recur-
rent aphthous stomatitis, and periodontal disease. We have investigated Iymphocytotox-
icity in 36 patients with various oral inflammatory diseases using an automated cell-counting 
system. This investigation demonstrated in vitro Iymphocytotoxicity for gingival epithelial 
target cells by aggressor lymphocytes harvested from patients with recurrent aphthous 
stomatitis and periodontal disease. This effect was not seen when the lymphocytes were har-
vested from normal subjects or from patients with other oral mucosal inflammatory diseases. 
The automated cell-counting system corresponded very well with the assay technique of ex-
clusion of supravital dye. 
Lymphocyte cytotoxicity for target cells is a 
method for evaluating specific lymphocyte stimu-
lation [1]. In vitro lymphocytotoxicity has been 
demonstrated for colonic epithelial target cells in 
chronic ulcerative colitis and granulomatous colitis 
[2,3 J; muscle target cells in polymyositis, der-
matomyositis, and sclerodermatomyositis [4-7 J; 
fibroblasts and epithelial target cells in progressive 
systemic scleroderma [7]; gingival epithelial target 
cells in recurrent aphthous stomatitis [8.9]; and 
gingival epithelial target cells and fibroblasts in 
periodontal disease [10,11]. 
We [9] have previously described Iympho-
cytotoxicity for gingival epithelial target cells 
as measured by exclusion of a supravital dye. 
try pan blue. This property of peripheral blood 
lymphocytes harvested from patients with recur· 
rent aphthous stomatitis (RAS) was not noted 
when we studied 14 normal subjects, 11 disease 
controls without oral lesions, and 10 disease con-
trols with oral lesions. Recently, we [Ill have 
demonstrated an increased Iymphocytotoxicity of 
peripheral blood lymphocytes of patients with 
destructive periodontal disease (PD) for gingival 
epithelial target cells when compared with perio-
dontal disease-free patients' lymphocytes. 
The present study was undertaken to investigate 
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further in vitro lymphocyte-epithelial cell interac-
tions between peripheral blood lymphocytes from 
patients with RAS, PD, and other oral inflamma-
tory diseases and gingival epithelial target cells, 
utilizing another method of assessing target cell 
cytotoxicity. 
MATERIALS ASD METHODS 
Subjects 
Thirty-six patients with oral inflammatory diseases 
were selected for study. All patients were examined for 
the presence of PD by a periodontist. Patients with a 
Ramfjord index [12] of PD (PDI) of less than 3.0 were 
studied as representatives of their specific disease. 
Patients with a PDI of equal to or greater than 4.0 were 
included as PD subjects. Patients with a PDI of equal to 
or greater than 3.0 and another oral inflammatory disease 
were not included among the study subjects. All patients 
were otherwise in good general health and were suffering 
only from the disease under study. 
In addition, 5 normal individuals with a PDI of less 
than 2.0 also served as normal subjects. These subjects 
denied a history of RAS, recurrent herpes simplex infec-
tions, and other oral inflammatory diseases. All were in 
good general health. 
Lymphocyte Preparation 
Aseptic techniques were adhered to throughout all 
steps. Twenty milliliters of heparinized venous blood was 
obtained from each volunteer. The lymphocytes were 
isolated from the buffy coat by the method of Terasaki, 
Mandell, Van De Water, and Edgington [13], as modified 
by Rogers, Sams, and Shorter [9 J, in which the differen-
tial adherence of polymorphonuclear neutrophils to poly-
styrene was used to separate the lymphocytes. 
The buffy coat and plasma were placed in a polysty-
rene Petri dish and incubated for 20 min at 37 0 C. The 
lymphocyte-rich suspension was transferred to a I5-ml 
Pyrex centrifuge tube and centrifuged at 700 X g for 10 
min. The pellet was suspended in fresh 2% Hank's 
solution (TC Hank's Solution, Difeo) for 15 min to lyse 
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any remammg erythrocytes. After centrifugation the 
lymphocytes were washed twice in TC-199 medium 
(Medium 199 with glutamine, Hank's Salts; Grand 
Island Biological Co.) and finally suspended in J mlof 
TC-199 medium. The concentration of the lymphocytes 
was determined by hemocytometer, and the viability of 
the lymphocytes was estimated by exclusion of trypan 
blue (0.5%) dye. The lymphocytes were finally suspended 
in TC-199 medium in a concentration of 1 x 10' viable 
lymphocytes per ml of solution. The initial viability 
routineh. exceeded 90%, and all preparations consisted of 
at least '95", mononuclear cells, as determined by direct 
microscopy. 
Gingival Epithelial Target Cell Preparation 
Fresh specimens of gingival epithelial tissue obtained 
from volunteer patients undergoing routine oral surgery 
were placed in Gib medium (Gib Medium 199 with 
glutamine; Grand Island Biological Co.) promptly after 
removaL The greater portion of lamina propria was 
trimmed away, and the remaining tissue was minced and 
subjected to trypsin (0.25%) for 2 hr (Fig. 1). The cells 
were filtered, washed 3 times with TC·199, and sus· 
pended in 1 ml offresh TC-199 medium. Cel! count and 
viability wcre estimated as with lymphocytes. Epithelial 
target cell suspensions were diluted to a concentration of 
1 x 10' cells per mL Initial viability routinely exceeded 
80%, and more than 95% of the cells had microscopic 
characteristics of basal cells. 
Assay Procedure 
Lymphocytotoxicity assays utilizing a suspension of 
peripheral blood lymphocytes incubated with allogeneic, 
trypsinized, gingival epithelial target cells were per· 
formed. Each assay was run by pairing an experimental 
subject w~th an oral inflammatory disease with a volun-
teer normal control subject who was free of oral inflam-
matory diseases by history and physical examination. 
Experimental and control subjects were matched by 
similar age and sex. The lymphocytes from each patient 
were combined with gingival epithelial target cells from 
the same volunteer patient at a 1:1 ratio (5 x 10' 
lymphocytes to 5 x 10' target cells). No serum was 
added. Penicillin 000 Vlml) and streptomycin (l00 
I'g/ml) were added to the culture medium after it was 
determined that this did not affect the paired resnlts. All 
cultures were set up in duplicate and incubated 18 hr at 
37 0 C. This incubation period was selected after prelimi. 
nary studies showed that significant lymphocytotoxicity 
was demonstrable at 18 hr. 
FIG. 1. Gingival epithelial tissue used for harvest of 
target cells that have been subjected to trypsinization 
(0.25%) for 2 hr. Note that cells of stratum basalis and 
spinosum are freed. (Hematoxylin and eosin; x 125.) 
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Data Collection 
The culture suspensions were analyzed with the. Co 1 
terChannelyzer Model 1000, a multithannelparticle·si :' 
analyzer used in conjunction with the Coulter Counl, 
ModelE. In order to distinguish lymphocytesfn 
epithelial target cells during the counting procedures, I 
lower'limit channel on the channelvzer was selected 
that only particles (cells) larger th~n lymphocytes w". 
counted (Fig. 21. The validity of the lower-limit cham 
channelyzer setting in Figure 2 was determined by com i-
ing lymphocytes alone and target cells alone to determi ), 
the portion of the counting range in which each wa, 
counted. The Iympbocyte counts were essentially COll1· 
plete at the lower·limit channel setting in repeated test,. 
Lymphoblast counts, obtained by direct microscopy. 
were low (1-3%) and did not interfere with target cell 
counting to an appreciable degree. By using the "inte· 
grate position" on the channelyzer, a numerical readout 
of eel! counts between the lower limit and upper limit was 
obtained. 
With the use of a micropipette, 0.1 ml of assay 
suspension was placed in 9.0 ml of 0.14 N saline for 
counting. Duplicate cell counts from each assay tube 
were obtained at the beginning and at the end of the 
18-hr experimental period. Target cell survival was 
determined by the following formula; 
Percent survival ~ I8-hr cell count 100 
O·hr cell count 
The cytotoxicity value L:lCT) was obtained by subtract-
ing the percent survival of the control subjects' assay 
from the experimental subjects' assay. Typical assay 
cell distribution is illustrated in Figure 3_ 
Reproducibility of counting was ~scertained by count-
ing one assay tube 10 separate times. The mean count 
was 2.989.80 cells ± 40.63 with a coefficient of variation of 
1.35%. Reproducibility of the dilution technique was 
assessed by counting 10 micropipetted dilutions of the 
same assay suspension. The mean count was 4,751.70 ;:i 
79.82 witb a coefficient of variation of J .68%. 
RESl'LTS 
Our purpose has been to studv the in vitro 
lymphocyte-epithelial cell interactions of periph-
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FIG. 2. Size distribution graph of lymphocytes and 
gingival epithelial target cells as they are passed throo,t1 
Coulter Counter and Channelyzer separately. Counting 
range between lower-limit channel (LLC) and uppe 
limit channel (ULC) is shown. Only target cells largif 
than lymphocytes are counted in this range. 
Noc,J976 
eralhlood lymphocytes harvested from patients 
with. HAS. PD. and other oral inflammatory dis-
eases, The median cytotoxicity values of lympho-
cytes harvested from patients with RAS and PD 
are 26,8 and17A. respectiveiy(Tab, I), Statistical 
analysis revealed that these two groups .represent 
different populations from the normal suhject and 
miscellaneous oral inflammatory disease subject 
populations hy pairwise comparison tests [14] (p ~ 
0,001). 
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FIG. 3. Typical assay cell distribution graph of 
lymphocyte· target cell cultures showing size distribution 
at 0 hr and after l8-hr incubation period. Counts were ob· 
tained only from lower-limit channel (LLC) to upper· 
limit channel (ULC) limits in Coulter Channelvzer to 
ensure that only target-cell survival was recorded.·Dif!"er-
encB in curves is due to cytolysis and cell death. 
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The 2 patients among the subjects having mis-
cellaneous oral inf1ammatory disease who .hada 
high cytotoxicity value appear to .represent falsely 
positive results .. One patient had acute herpetic 
gingivostomatitis with marked gingival involve-
ment; however, 2 similar patients did not demon-
strate high cytotoxicity values, The other patient 
had pemphigus vulgaris with oral lesions. She was 
edentulous, having undergone full-mouth extrac-
tions for advanced periodontal disease 2 years 
previously, Two other patients with oral lesions of 
pemphigus vulgaris did not demonstrate high cyto-
toxicity values. 
Previous studies from our laboratories [9] have 
demonstrated a significant lymphocytotoxicity for 
gingival epithelial target cells as assessed by try-
pan blue dye exclusion when the lymphocytes were 
harvested from patients with RAS. The scatter-
gram (Fig, 4) and Table II depict the correspon-
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}'JG. 4. Scattergram depicting cytotoxicity values for 
patient groups studied. There is no statistical1y signifl-
cant difference between the Coulter Counter data and 
the trypan blue data within each group. • ~ Trypan 
hlue: 0 ~ Coulter Counter. 
TARLE l. Cytotoxicity values u'ith Coulter Counter assay technique 
-----~~ 
Patient group 7\urnher 
Normal subjects 5 
Recurrent aphthous stomatitis 8 
Periodontal disease 16 
Miscellaneous oral inflammation 12 
:\.'iedian 
0.5 
26.8 
1i .4 
4.0 
Rangp 
-3.0 to 5.9 
10.0 to 46,2 
4.5 to 42.0 
-3,4 to 42,4 
Sign€d rank lest 
NS 
p 0.005 
p " 0.004 
p ~ 0.021" 
" Pairwise comparison between the 3 abnormal groups indicated that recurrent aphthous stomatitis and periodontal 
disease differed signitlcantly from the miscellaneous oral inflammation group (p ~ (1.001 hased on a one-sided rank 
sum test) but not from each other. 
TARLE II. Cytotoxicity values with trypan blue assay technique" 
~------------.------------------
Pallcnt group Numher Median Ran~e Sign-ed rank test 
~-.~--~---~-------~~~-
Normal subjects 17 1.0 2.0 to 4.0 P ~ O.OOT' 
Recurrent aphthous stoma tit is 26 18.0 8.0 to :36.0 p 0.0001' 
Periodontal disease 7 10,0 4.0 to 13.0 p ~ 0.008 
Miscellaneous oral inflammation 1:1 3.0 -3.0 to 24.0 P 0.005 
" Some of this data has been published elsewhere [9]. 
,. P value is statistically significantly different from zero but this is not meaningful as all observations are very close 
to zero (range ~~2.0 to 4.01. 
'Pairwise comparison between the 3 ahnormal groups indicated that recurrent aphthous stomatitis differed 
';ignificantly from periodontal disease and miscellaneous oral inflammation groups (p 0.001 based on a one-sided 
rank sum testl. 
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dence of the cytotoxicity values whether assessed 
by exclusion of trypan blue dye or by Coulter coun-
ter assay techniques. Exclusion of the 2 falsely posi· 
tive results in the miscellaneous oral inflammatory 
disease subject group would give a median of 3.0 
and a range of -3.4 to 6.9 (Tab. O. 
DISCUSSION 
The present investigation demonstrates, by two 
techniques, a significant in vitro lymphocytotoxic-
ity for gingival epithelial target cells by aggressor 
lymphocytes harvested from patients with RAS 
and PD. The survival of the target cells was 
reduced after incubation with lymphocytes har· 
vested from patients with RAS and PD. This effect 
was not seen when the lymphocytes were harvested 
from normal subjects and from patients with other 
oral mucosal inflammatory diseases. We conjec-
ture that these investigations may help elucidate 
the role of the lymphocyte in the pathogenesis of 
these diseases. In addition, this assay technique 
may provide an in vitro method of testing efficacy 
of drugs used to treat these diseases. 
The assay technique is consistent and reproduci· 
ble. The reproducibility of the Coulter counting 
procedures and dilution techniques was confirmed 
by counting 10 separate aliquots of the same tube, 
with a coefficient of variation of 1.35%; and by 
counting 10 tubes one time each, with a coefficient 
of variation of 1.68%. Each assay was made up in 
duplicate tubes and a duplicate cell count was 
obtained for each tube. The consistency of the 
control incubations was confirmed by pairing nor-
mal subjects' cultures. There were no significant 
differences in target cell survival in these tests. 
The disease specificity of the lymphocytotoxicity 
reported herein is excellent. No patient with active 
lesions of RAS or PD with a PDI of equal to or 
greater than 4.0 has failed to demonstrate lym· 
phocytotoxicity. Conversely, normal subjects and 
patients with a wide variety of miscellaneous oral 
inflammatory conditions described in this report 
and in our previous report [9J showed no Iym-
phocytotoxicity, with the exception of the 2 
patients described above. In addition, none of the 
11 disease controls who did not have oral involve-
ment demonstrated Iymphocytotoxicity [9 J. 
The Iymphocytotoxicity reported herein is mani-
fested in a primary cell line in the first 18 hr of 
culture. The absence of allogeneic cytotoxicity in 
35 control assays and virtually identical results 
with both autologous and allogeneic target cells is 
strong evidence against the theory that 
histoincompatibility is the cause of target-cell 
death [9J. 
The Iymphocytotoxicity assays are carried out 
without addition of exogenous complement sources 
or exogenous or autologous serum. The amount of 
serum carried throughout the harvest procedure 
must be extremely small. The aggressor cell popu-
Vol. 67, No.5, Part i of 2 par 
lation consisted of at least 95% mononuclear celc 
Preliminary data of the mononuclear populatir t 
show that the percentages of T-Iymphocytes al ( 
B-lymphocytes are within the range of normal .. 
ascertained in our laboratories [15] and are comp 
rable to populations of lymphocytes harvested I \ 
the Ficoll-Hypaque technique. . 
Further studies are being conducted to dete' 
mine in which lymphocyte sub population the cyt ) 
toxic lymphocytes may be found. T-cell-enriched 
B-cell-enriched, and mixed lymphocyte popub 
tions are being studied for the presence of lynl 
phocytotoxicity. 
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